» Articles » PMID: 17158545

Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2006 Dec 13
PMID 17158545
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Renal cell cancer (RCC) is a heterogeneous disease consisting of different histologic types. Major advances have been accomplished during the last 15 years in our understanding of the genetic events that initiate RCC. These advances were greatly facilitated by meticulous clinical description and registration of patients with familial predisposition to RCC. The cloning of the susceptibility genes that underline familial predisposition to RCC has offered entry points into the signaling pathways that are also deregulated in sporadic RCC. Biochemical studies of these signaling pathways and target validation experiments have already culminated in the discovery and clinical application of small molecules with promising activity in RCC. In this article, we highlight the molecular genetic features of RCC that are more directly related to identification and validation of promising targets for molecular therapy.

Citing Articles

Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients.

Armesto M, Nemours S, Arestin M, Bernal I, Solano-Iturri J, Manrique M Int J Mol Sci. 2024; 25(13).

PMID: 38999991 PMC: 11241516. DOI: 10.3390/ijms25136881.


APPL1 Is a Prognostic Biomarker and Correlated with Treg Cell Infiltration via Oxygen-Consuming Metabolism in Renal Clear Cell Carcinoma.

Yang M, Gong C, Song K, Huang N, Chen H, Gong H Oxid Med Cell Longev. 2023; 2023:5885203.

PMID: 36846720 PMC: 9957629. DOI: 10.1155/2023/5885203.


A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma.

Alchahin A, Mei S, Tsea I, Hirz T, Kfoury Y, Dahl D Nat Commun. 2022; 13(1):5747.

PMID: 36180422 PMC: 9525645. DOI: 10.1038/s41467-022-33375-w.


Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review.

Feng C, Lyu Y, Gong L, Wang J Nutrients. 2022; 14(11).

PMID: 35684073 PMC: 9182762. DOI: 10.3390/nu14112274.


The tumor microenvironment in renal cell cancer.

Mier J Curr Opin Oncol. 2019; 31(3):194-199.

PMID: 30985497 PMC: 6467495. DOI: 10.1097/CCO.0000000000000512.